Internal Medicine, Hematology & Oncology · Honolulu, HI
NPI
1194792119
Since 2006
Specialty
Internal Medicine, Hematology & Oncology
Code 207RH0003X
Group practices
2
Medicare group memberships
Hospitals
5
Hospital affiliations
1329 Lusitana St Ste 307
Honolulu, HI, 96813
Phone (808) 524-6115
Groups this clinician bills Medicare through
Medicare paid, 2024
$1.8M
90,071 services
Medicare patients, 2024
667
Average age 77
Drug cost, 2024
$6.3M
2,664 prescriptions
Company payments, 2025
$3,735
From 49 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Arnold K Yee was code J0897 (injection, denosumab, 1 mg), 7,448 times for 37 patients. In total Arnold K Yee billed 90,071 services in 133 codes, and Medicare paid $1.8M.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2019-07-18.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J0897 Injection, denosumab, 1 mg | Office | 7,448 | 37 | $20.76 | $155K |
| J0885 Injection, epoetin alfa, (for non-esrd use), 1000 units | Office | 3,719 | 20 | $6.11 | $23K |
| J1100 Injection, dexamethasone sodium phosphate, 1 mg | Office | 1,442 | 27 | $0.09 | $129 |
| 85025 Blood Count | Office | 1,335 | 285 | $7.51 | $10K |
| 36415 Venipuncture Blood Collection | Office | 1,298 | 288 | $7.22 | $9,367 |
| 99214 Office E&M - Established | Office | 1,075 | 416 | $99.08 | $107K |
| 99213 Office E&M - Established | Office | 989 | 381 | $69.15 | $68K |
| J2405 Injection, ondansetron hydrochloride, per 1 mg | Office | 612 | 17 | $0.07 | $44.33 |
| 96372 Injection Administration | Office | 582 | 100 | $11.15 | $6,488 |
| J2469 Injection, palonosetron hcl, 25 mcg | Office | 580 | 12 | $0.69 | $398 |
| 80053 Clinical Chemistry | Office | 524 | 166 | $10.23 | $5,362 |
| 80048 Clinical Chemistry | Office | 376 | 135 | $8.22 | $3,090 |
| 80076 Clinical Chemistry | Office | 355 | 124 | $7.94 | $2,817 |
| 96367 Intravenous Infusion, Hydration | Office | 302 | 30 | $24.30 | $7,340 |
| J3420 Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | Office | 298 | 28 | $0.88 | $263 |
By year: 2022 $1.2M for 75,898 services; 2023 $344K for 23,342 services; 2024 $1.8M for 90,071 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 85025 Blood Count | 1,335 | 285 | $7.51 | $10K |
| 36415 Venipuncture Blood Collection | 1,298 | 288 | $7.22 | $9,367 |
| 80053 Clinical Chemistry | 524 | 166 | $10.23 | $5,362 |
| 80048 Clinical Chemistry | 376 | 135 | $8.22 | $3,090 |
| 80076 Clinical Chemistry | 355 | 124 | $7.94 | $2,817 |
| 83615 Clinical Chemistry | 103 | 48 | $5.92 | $610 |
| 84153 Clinical Chemistry | 96 | 17 | $17.83 | $1,712 |
| 83735 Clinical Chemistry | 85 | 15 | $6.42 | $546 |
| 84443 Clinical Chemistry | 71 | 31 | $16.46 | $1,169 |
| 82728 Clinical Chemistry | 61 | 37 | $13.36 | $815 |
Medicare prescription drug claims, 2024
In 2024, the drug Arnold K Yee prescribed most often to Medicare patients was Anastrozole, with 473 prescriptions and refills. In total Arnold K Yee wrote 2,664 Medicare prescriptions that cost $6.3M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Anastrozole Generic | 473 | 1,339 | 140 | $25K |
| Tamoxifen Citrate Generic | 143 | 431 | 39 | $6,384 |
| Letrozole Generic | 125 | 343 | 38 | $2,743 |
| Alendronate Sodium Generic | 109 | 302 | 40 | $2,562 |
| Exemestane Generic | 85 | 228 | 26 | $11K |
| Procrit Epoetin Alfa | 68 | 68 | Under 11 | $83K |
| Xgeva Denosumab | 67 | 71 | Under 11 | $213K |
| Levothyroxine Sodium Generic | 54 | 153 | 17 | $409 |
| Xtandi Enzalutamide | 54 | 54 | Under 11 | $754K |
| Eliquis Apixaban | 49 | 93 | 11 | $53K |
| Pantoprazole Sodium Generic | 40 | 88 | 19 | $649 |
| Loperamide Loperamide Hcl | 35 | 35 | 21 | $463 |
| Oxycodone Hcl Generic | 35 | 35 | Under 11 | $299 |
| Potassium Chloride Generic | 34 | 68 | 12 | $588 |
| Fosaprepitant Dimeglumine Generic | 32 | 32 | Under 11 | $2,867 |
Brand drugs: - claims; generic drugs: 1,883 claims; opioid claims: 75.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Arnold K Yee $3,735 ($3,735 in general payments such as food, travel and fees) from 49 companies. The largest payer was Pfizer Inc. with $589.
| Company | Payments | Amount |
|---|---|---|
| Pfizer Inc. PFE | 14 | $589 |
| Janssen Biotech, Inc. JNJ | 11 | $247 |
| Abbvie Inc. ABBV | 13 | $228 |
| Array Biopharma Inc PFE | 5 | $150 |
| Karyopharm Therapeutics Inc. KPTI | 3 | $149 |
| Genzyme Corporation SNY | 5 | $148 |
| AstraZeneca Pharmaceuticals LP AZN | 7 | $144 |
| Novartis Pharmaceuticals Corporation NVS | 6 | $133 |
| Merck Sharp & Dohme LLC MRK | 5 | $123 |
| Incyte Corporation INCY | 5 | $121 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.